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INTRODUCTION
INSULIN is a complex polypeptide hormone, prepared in crystalline form frorn
the pancreas of suitable animals and available for the parenteral administration to
patients whose endogenous supply of insulin is insufficient to maintain normal
carbohydrate metabolism. About one-third of diabetic patients need insulin, and
a great variety of commercial preparations, some newly introduced on the
market, are available for their treatment.
PREPARATIONS OF INSULIN*
Much of the insulin used in Britain has, until recently, been derived from ox
pancreas, whereas pork insulins predominate in Europe. All standard insulin
preparations are impure and stimulate the production of antibodies. Pork insulins
are less antigenic than beef since the structure of the former resembles the human
form more closely than the latter. Newer highly purified pork insulins have been
subjected to further re-crystallization and gel-filtration, and only rarely provoke
antibody formation. Purified beef insulin preparations from which immunogenic
proinsulin has been largely removed (less than 20 ppm) have just been introduced.
Preparations of insulin can be divided into three groups, depending on their
length and speed of action, namely, short-acting with rapid onset, intermediate
and long-acting. Except for the short-acting soluble insulins, all other types have
been modified to delay absorption and increase the duration of action. This is
achieved by the addition of zinc or a protein, or both, in the presence of a suitable
buffer.
SHORT-ACTING INSULINS
Soluble insulin (insulin injection BP, unmodified or regular, SI) is a clear
aqueous solution of beef insulin with a pH of 3.0 to 3.5. SI acts quickly and more
intensely than the modified insulins.
Neutral soluble insulin (Nuso, neutral injection BP) is a crystalline insulin
derived from beef or pork pancreas with a pH of 6.6 to 7.7 Actrapid MC
(Novo) and Insulin Leo Neutral (Nordisk) are neutral highly purified pork insulin
preparations. Semilente is a neutral suspension of zinc insulin (IZS) in amorphous
form prepared from beef or pork insulin, and Semitard MC (Novo) is the equiva-
lent in highly purified pork insulin. Semilente (Novo) is proinsulin free (PIF)
pork insulin.
* A detailed list of the preparations of insulin in current use may be obtained from Dr. Marie
Maguire, Drug Information Centre, The Pharmacy, Royal Victoria Hospital, Belfast
BT12 6BA.
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for the treatment of diabetic ketosis and coma and for surgical emergencies. When
injected subcutaneously their action lasts from i to 8 hours, with a peak between
1+ and 4 hours. Neutral soluble insulin and the highly purified pork preparations
have a slightly faster rate of action than SI, probably because the pH of the latter
has to rise before it becomes biologically active and possibly to a lack of insulin
binding in the plasma by the purified insulins. The action of Semilente and
Semitard lasts between 11 and 14 hours and is at its peak between 4 and 9 hours.
INTERMEDIATE INSULINS
Isophane insulin BP (NPH) is a suspension of beef crystalline insulin, prota-
mine and zinc, buffered with phosphate (pH 7.1 to 7.4). Leo Retard is a neutral,
highly purified micro-crystalline pork isophane preparation. Both SI and Leo
Neutral can be mixed with their appropriate isophane preparation (beef for the
former and pork for the latter) without causing loss of action of either due to
precipitation of free zinc. Mixtard (Leo) is a preparation containing a mixture of
Leo Neutral (30 per cent) with Leo Retard (70 per cent). Globin zinc insulin BP
is an acidic solution of beef insulin, modified by the addition of a suitable globin
and zinc (pH 3.0 to 3.5). Biphasic insulin BP is a neutral mixture of beef insulin
crystals (75 per cent) suspended in a solution of pork insulin. Rapitard (Novo)
consists of a mixture of PIF beef insulin crystals in a solution of highly purified
pork insulin. Lente insulin (IZS) is a neutral mixture of seven parts of crystalline
zinc suspension (Ultralente) and three parts of amorphous suspension (Semilente).
Lentard (Novo) is a PIF beef preparation of Lente. Monotard MC (Novo) is the
highly purified pork equivalent of Lente.
The action of Isophane, Leo Retard, Globin Zinc and Rapitard commences at
1-2 hours and continues for 24 hours, with maximum effect between 4 and 12
hours. There are minor variations between the different preparations. Lente,
Lentard and Monotard have a slightly slower onset of action (22 hours) and last
fully 24 hours, with the peak response between 6 and 14 hours.
LONG-ACTING INSULINS
Protamine zinc insulin (PZI) is a combination of beef or pork insulin with
added protamine and zinc, phosphate buffered to a pH of 6.9 to 7.3. Ultralente
insulin (IZS) is a neutral suspension of crystalline beef insulin. Ultratard (Novo)
is a PIF preparation of Ultralente. Onset of action of these preparations is delayed
for 4 hours and continues for 30 or more hours, depending on the dose, with the
maximum effect between 10 and 18 hours.
Highly purified pork insulins were introduced for clinical use in Britain in
1975. These insulins differ from standard beef or pork insulin and patients accus-
tomed to ordinary preparations may develop hypoglycaemia if they are changed
to an equivalent dose of a highly purified insulin because of lack of resistance.
Highly purified pork insulins do not give rise to antibodies in previously untreated
diabetics, or, if they do, these are of very low titre, and there may be a modest,
sometimes substantial drop (immediate or delayed) in insulin requirement on
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when substituting one of these preparations and further adjustments, either up or
down, should be carefully supervised. Cutaneous sensitivity reactions and lipo-
atrophy have been largely abolished, and remission periods are said to last longer.
Purified beef insulins, from which immunogenic proinsulin substances have
been largely reduced (less than 20 ppm) became available for clinical use early in
1976. Patients currently maintained on Novo Lente, Ultralente and Rapitard can
be changed to the equivalent PIF preparation without readjustment of the dose.
INSULIN STRENGTHS
Insulin is standardised in International Units to ensure that the dose remains
constant. With few exceptions, insulin is available in 40 and 80 unit strengths.
Recently, preparations containing 100 units per ml (U-100) have been introduced
in the USA and Canada with the object of phasing out U-40 and U-80. However,
U-40 and U-80 preparations are still listed in the USP (18th ed., 1975).
INDICATIONS FOR INSULIN THERAPY
Insulin is required for the treatment of diabetic ketosis and for all diabetics
who cannot be kept in good health without it. It should be avoided in the obese,
unless it is required temporarily to treat ketosis, to cover infections, surgical
operations and to relieve diabetic vulvitis. Insulin is usually indicated for patients
with active retinopathy, neuropathy or nephropathy, for young diabetics with
cataracts and during pregnancy. Obese patients with complications, however, gain
little from the addition of insulin if the blood glucose can be kept at normal levels
without it.
METHODS OF USING INSULIN
The range of insulin preparations is such that it should be possible to achieve
excellent control in most stable diabetics and good control in the majority of
brittle diabetics. The selection of a suitable regime depends on the patient, the
nature of the diabetes and the experience of the physician.
TWICE DAILY REGIMES
Soluble insulin, Nuso, Actrapid MC and Leo Neutral, injected 10 to 20
minutes before the morning and evening meals, are used for the initial stabilisation
of new diabetics and for the treatment of diabetic ketosis and other complications.
It is probably advisable now to start new diabetics on a highly purified pork or
beef preparation. The disadvantage of extra cost (approximately the same to more
than twice as expensive) is balanced by smaller doses and freedom from allergic
side effects.
When employed twice daily they usually provide control of the plasma glucose
level equal or superior to most single dose injection regimes. The chief disadvan-
tage is the short duration so that patients with severe diabetes frequently show
hyperglycaemia for some hours before the next injection of insulin is due. This
fluctuation makes stabilisation difficult and hypoglycaemia results if the dose of
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be overcome by combining Isophane with one or both doses of SI, allowing 3 or
4 units of Isophane for each unit of SI. This combination prolongs the action of
the insulin and allows a reduction in the dose of SI and the danger of hypo-
glycaemia. A similar effect can be achieved with a combination of Actrapid MC
or Semitard MC and Montard MC, by a mixture of Semilente and Lente insulin
or Leo Neutral and Retard. The combination of a quick and intermediate-acting
insulin twice daily provides the most effective control for patients with severe or
brittle diabetes.
SINGLE DOSE REGIMES
Any of the intermediate insulins (Isophane, Leo Retard, Lente or Monotard
MC) may provide acceptable control for 18 to 24 hours after a morning injection.
The method is satisfactory for mild diabetics (approximately one-third of those
requiring insulin). These preparations frequently provide good control in the
afternoon and evening without affecting appreciably the morning hyperglycaemia.
The administration of a short-acting insulin (SI, Leo Neutral, Actrapid MC or
Semitard MC) with the morning dose or the use of Mixtard or Rapitard may
avoid this difficulty. Sometimes the converse is seen, when control in the morning
and afternoon is good, but hyperglycaemia returns in the evening and persists
overnight. Such a pattern requires the addition of a second dose of a quick-acting
or intermediate insulin before the evening meal. Alternatively, the effect of a
morning dose of Lente or Lentard can be protracted by the addition of some
Ultralente or Ultratard. Patients needing more than 60 units per day can rarely
be controlled satisfactorily on a single morning injection of an intermediate or
long-acting preparation. In general, single dose regimes are unsuitable for children
and adolescents, pregnant diabetics, for patients with diabetic complications, for
those with infections or ketosis and for those undergoing surgical operations.
INSULIN MIXTURES
Soluble insulin and Isophane can be injected together in the same syringe
without their individual actions being altered significantly. Various combinations
of the insulin zinc suspensions and highly purified insulins may be tried to obtain
relatively constant plasma glucose levels throughout the 24 hours. Actrapid MC,
Leo'Neutral, Semilente or Semitard MC may be added to Lente to increase the
speed of action earlier in the day, or Ultralente may be added to Semilente or
Lente, or Monotard MC to Semitard MC, to provide a protracted efiect. It must
be noted that the non-antigenic properties of highly purified insulins are destroyed
if they are mixed with insulins which are not of highly purified pork origin. The
admixture of SI and Lente is not recommended, since the two preparations differ
in pH; Actrapid MC or Nuso are preferred.
ADVERSE REACTIONS TO INSULIN
These may be local or general. A local stinging or a tender indurated swelling
at the site of injection is seen in about 40 per cent of patients seven to ten days
after insulin treatment has been started with the older preparations. The cutaneous
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the patient should be reassured and treatment need not be interrupted. Should
they persist it is advisable to change to a highly purified preparation. True insulin
allergy is rare and is similar to the allergy caused by other antigens. Most insulin
allergies occur with modified insulins derived from the more antigenic beef pre-
parations, so that it may be necessary to rely on a highly purified neutral pork
soluble insulin. Lipoatrophy (insulin atrophy) is the most frequent long-term
adverse reaction to standard insulins but it is rarely seen with the new purified
preparations. The cause is unknown although antigenic impurities of insulin may
be a factor and, until recently, there was no reliable cure. Recently it has been
shown that the injection of neutral soluble insulin into the affected area or
changing to a highly purified preparation is beneficial. Lipohypertrophy is rare
and consists of a large subcutaneous mass of fatty tissue which develops at the
site of repeated injections of insulin. The swelling may disappear when insulin is
no longer injected, but large tumours may require surgical removal.
CONCLUSIONS
The variety of current insulin preparations is so extensive that the successful
treatment of all insulin-dependent diabetics should be possible whether they are
stable or not. Unfortunately, the range is so wide that few general physicians
can gain expert knowledge of all varieties. However, the soluble insulins, Isophane,
the highly purified preparations and the insulin zinc suspensions cover the needs
of most patients. Special combinations, arrived at by trial and error, are usually
necessary for the minority with brittle diabetes.
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